Category: Approval/Launch Region: North America · United States Company: Glenmark Pharmaceuticals Inc Usa

Glenmark Pharma Gets Us Fda Approval For Generic Taytulla Capsules

Glenmark Pharma Gets Us Fda Approval For Generic Taytulla Capsules
Glenmark Pharmaceuticals Inc., Usa (Glenmark) Has Received Final Approval By The United States Food & Drug Administration (Fda) For Norethindrone Acetate And Ethinyl Estradiol Capsules And Ferrous Fumarate Capsules, 1 Mg/20 Mcg, The Generic Version Of Taytulla Capsules, Of Allergan Pharmaceuticals International Limited. According To Iqvia Sales Data For The 12 Month Period Ending May 2022, The Taytulla Capsules Market Achieved Annual Sales Of Approximately $85.9 Million. Glenmark

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!